This section is provided for qualified healthcare practitioners as professional education. It summarises selected ingredient-level, pathway-level and traditional-use research relating to Ayurvedic herbs, inflammation, mild arthritis / mild osteoarthritis symptoms and mild joint comfort. It does not represent additional ARTG indications for RADIA.
RADIA is relevant to practitioners interested in Ayurvedic inflammation support, mild joint comfort, mild arthritis / mild osteoarthritis symptom research, botanical anti-inflammatory pathway research and traditional musculoskeletal support.
Tinospora sinensis is included as a key ingredient in RADIA and is relevant to practitioner education around Ayurvedic and traditional inflammatory pathway research. Tinospora species have been discussed in professional literature in relation to inflammatory signalling, antioxidant pathways, immune pathway research and musculoskeletal support contexts. This supports ingredient-level education only and should not be presented as a claim for rheumatoid arthritis or serious inflammatory disease.
Boerhavia diffusa is traditionally used in Ayurvedic medicine and has been discussed in professional literature in relation to inflammation, antioxidant activity, traditional musculoskeletal support and general wellbeing research.
Moringa oleifera is widely discussed in professional literature in relation to antioxidant compounds, inflammatory pathway research, polyphenols and general musculoskeletal health research.
Gastrodia elata, Dioscorea villosa and Oenothera biennis support the broader botanical formula profile. Practitioner interest may include traditional pain and stiffness support, inflammatory pathway education, botanical constituents, oxidative stress research and mild joint comfort.
The combination of Tinospora, Boerhavia, Moringa, Gastrodia, Dioscorea and Oenothera supports practitioner education around inflammation relief and mild arthritis / mild osteoarthritis symptom support. Broader research areas such as rheumatoid arthritis, severe osteoarthritis, joint swelling, cartilage regeneration, COX-2 inhibition or disease-modifying effects should remain professional background only and not be presented as product indications.
This information is provided for practitioner education only and does not represent additional ARTG indications for RADIA.
References available to registered practitioners on request.